Serum Blood Urea Nitrogen and Plasma Brain Natriuretic Peptide and Low Diastolic Blood Pressure Predict Cardiovascular Morbidity and Mortality Following Discharge in Acute Decompensated Heart Failure Patients

被引:28
|
作者
Chen, Chun-Yen [1 ,2 ,3 ]
Yoshida, Akemi [1 ]
Asakura, Masanori [1 ]
Hasegawa, Takuya [1 ]
Takahama, Hiroyuki [1 ]
Amaki, Makoto [1 ]
Funada, Akira [1 ]
Asanuma, Hiroshi [1 ]
Yokoyama, Hiroyuki [1 ]
Kim, Jiyoong [1 ]
Kanzaki, Hideaki [1 ]
Kitakaze, Masafumi [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan
[2] Mackay Mem Hosp, Dept Internal Med, Div Cardiovasc, Taipei, Taiwan
[3] Mackay Med Nursing & Management Coll, Taipei, Taiwan
关键词
Blood pressure; Blood urea nitrogen; Brain natriuretic peptide; Heart failure; INITIATE LIFESAVING TREATMENT; HOSPITALIZED-PATIENTS; ORGANIZED PROGRAM; OPTIMIZE-HF; SURVIVAL; OUTCOMES; TRIAL; RISK; DYSFUNCTION; PROGNOSIS;
D O I
10.1253/circj.CJ-12-0040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with heart failure (HF) have a high risk of cardiovascular (CV) death and re-hospitalization. The purpose of the present study was therefore to investigate predictors of CV death and re-hospitalization for acute decompensated HF (ADHF). Methods and Results: A total of 225 patients aged 67.2 +/- 15.2 years, including 134 men (59.6%), who were hospitalized for ADHF between 2008 and 2009, were followed up. After discharge, the relationship between clinical parameters and CV events (ie, CV death or re-hospitalization for HF) was examined. Follow-up was continued until 30 April 2011. The most important predictors of re-hospitalization were serum blood urea nitrogen (BUN; adjusted hazard ratio [HR], 1.02; 95% confidence interval [CI]: 1.00-1.03, P=0.01), plasma brain natriuretic peptide (BNP; adjusted HR, 1.85; 95% CI: 1.12-3.04, P=0.02), and diastolic blood pressure (DBP; adjusted HR, 0.97; 95% CI: 0.94-1.00, P=0.049). The only predictor of CV mortality was a high BUN (adjusted HR, 1.05; 95% CI: 1.01-1.09, P=0.01). Conclusions: High serum BUN (>= 22.5 mg/dl), high plasma BNP (>= 250 pg/ml), and low DBP (< 60 mmHg) predict CV events in patients hospitalized for ADHF. These factors may identify high-risk patients for CV events and provide therapeutic targets for managing HF. (Circ J 2012; 76: 2372-2379)
引用
收藏
页码:2372 / 2379
页数:8
相关论文
共 50 条
  • [31] Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart Failure
    Fukuda, Hiroki
    Suwa, Hideaki
    Nakano, Atsushi
    Sakamoto, Mari
    Imazu, Miki
    Hasegawa, Takuya
    Takahama, Hiroyuki
    Amaki, Makoto
    Kanzaki, Hideaki
    Anzai, Toshihisa
    Mochizuki, Naoki
    Ishii, Akira
    Asanuma, Hiroshi
    Asakura, Masanori
    Washio, Takashi
    Kitakaze, Masafumi
    SCIENTIFIC REPORTS, 2016, 6
  • [32] Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure
    Hidetada Fukuoka
    Koichi Tachibana
    Yukinori Shinoda
    Tomoko Minamisaka
    Hirooki Inui
    Keisuke Ueno
    Soki Inoue
    Kentaro Mine
    Kumpei Ueda
    Shiro Hoshida
    BMC Cardiovascular Disorders, 20
  • [33] Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure
    Fukuoka, Hidetada
    Tachibana, Koichi
    Shinoda, Yukinori
    Minamisaka, Tomoko
    Inui, Hirooki
    Ueno, Keisuke
    Inoue, Soki
    Mine, Kentaro
    Ueda, Kumpei
    Hoshida, Shiro
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [34] Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure
    Jujo, Kentaro
    Minami, Yuichiro
    Haruki, Shintaro
    Matsue, Yuya
    Shimazaki, Kensuke
    Kadowaki, Hiromu
    Ishida, Issei
    Kambayashi, Keigo
    Arashi, Hiroyuki
    Sekiguchi, Haruki
    Hagiwara, Nobuhisa
    ESC HEART FAILURE, 2017, 4 (04): : 545 - 553
  • [35] The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute decompensated heart failure
    Green, Sandy M.
    Redmond, Patrick
    Januzzi, James L.
    Aleryani, Sarnir
    Lee-Lewindrowski, Cizabeth
    Sluss, Patrick
    Lewandrowski, Kent B.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (03) : 473 - 476
  • [36] Brain natriuretic peptide plasma level may predict acute decompensation in chronic heart failure patients during carvedilol titration
    Jourdain, P
    Funck, F
    Bellorini, M
    Fulla, Y
    Guillard, N
    Loiret, J
    Thebault, B
    Desnos, M
    EUROPEAN HEART JOURNAL, 2003, 24 : 530 - 530
  • [37] Prognostic significances of systolic blood pressure and brain natriuretic peptide at admission in acute heart failure: A report from the ATTEND registry
    Sato, NNaoki
    Kajimoto, K.
    Takano, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 235 - 236
  • [38] Does blood urea concentration predict early mortality in patients hospitalised with decompensated heart failure better than estimated glomerular filtration rate?
    Jackson, C. E.
    Austin, D.
    Tsorlalis, I. K.
    Dalzell, J. R.
    Myles, R. C.
    Rodgers, J.
    Stewart, N.
    Spooner, R.
    Petrie, M. C.
    Cobbe, S. M.
    McMurray, J. J. V.
    HEART, 2008, 94 : A107 - A107
  • [39] Comparison of prognostic significance of amino-terminal pro-brain natriuretic peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure
    Shenkman, Heather J.
    Zareba, Wojciech
    Bisognano, John D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 1143 - 1145
  • [40] Effect of Telmisartan on Ambulatory Blood Pressure Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of Serum Albumin in Hemodialysis Patients
    Hidetaka Shimada
    Kenichiro Kitamura
    Makoto Anraku
    Taku Miyoshi
    Masataka Adachi
    Do Gia Tuyen
    Shiho Wakamatsu
    Hiroshi Nonoguchi
    Motoko Tanaka
    Kimio Tomita
    Hypertension Research, 2005, 28 : 987 - 994